Omnipod Horizon System in Children with Type 1 Diabetes
Dec 8, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
The first study conducted on the Omnipod Horizon System that explores the effectiveness and safety parameters.
The Omnipod 5, Powered by Horizon System, is a hybrid closed loop automated insulin delivery device. This system is compatible with the Dexcom G6 sensor. A mobile phone or personal diabetes manager is used to switch to automatic mode, administer bolus doses, and control different settings. A unique feature of the device is that it uses custom-built glucose control. The precise targets implanted ranged from 110 to 150 mg d/L. These targets are modifiable based on the time of day. Another beneficial feature of this device is called "Hypo Protect," which prevents the patient from experiencing a hypoglycemia episode. Exercising is an excellent example of when this feature is being activated. This device better improves a patient’s glycemic control over time because it learns the patient's insulin delivery schedule....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.